2,383
Views
78
CrossRef citations to date
0
Altmetric
Commentary

Hepatitis E vaccine development

A 14 year odyssey

, , , , &
Pages 823-827 | Published online: 01 Jun 2012

References

  • Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, et al. Hepatitis E. Lancet 2012; 379 In press
  • Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008; 48:494 - 503; http://dx.doi.org/10.1016/j.jhep.2007.12.008; PMID: 18192058
  • Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int 2008; 28:1190 - 9; http://dx.doi.org/10.1111/j.1478-3231.2008.01840.x; PMID: 18662274
  • Dalton HR, Hazeldine S, Banks M, Ijaz S, Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet 2007; 369:1260; http://dx.doi.org/10.1016/S0140-6736(07)60595-9; PMID: 17434400
  • Teshale EH, Howard CM, Grytdal SP, Handzel TR, Barry V, Kamili S, et al. Hepatitis E epidemic, Uganda. Emerg Infect Dis 2010; 16:126 - 9; http://dx.doi.org/10.3201/eid1601.090764; PMID: 20031058
  • Zhuang H, Cao XY, Liu CB, Wang GM. Epidemiology of hepatitis E in China. Gastroenterol Jpn 1991; 26:Suppl 3 135 - 8; PMID: 1909252
  • Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376:895 - 902; http://dx.doi.org/10.1016/S0140-6736(10)61030-6; PMID: 20728932
  • Li SW, Zhang J, Li YM, Ou SH, Huang GY, He ZQ, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005; 23:2893 - 901; http://dx.doi.org/10.1016/j.vaccine.2004.11.064; PMID: 15780738
  • Zhang J, Gu Y, Ge SX, Li SW, He ZQ, Huang GY, et al. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine 2005; 23:2881 - 92; http://dx.doi.org/10.1016/j.vaccine.2004.11.065; PMID: 15780737
  • Tang X, Yang C, Gu Y, Song C, Zhang X, Wang Y, et al. Structural basis for the neutralization and genotype specificity of hepatitis E virus. Proc Natl Acad Sci U S A 2011; 108:10266 - 71; http://dx.doi.org/10.1073/pnas.1101309108; PMID: 21642534
  • Li S, Tang X, Seetharaman J, Yang C, Gu Y, Zhang J, et al. Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction. PLoS Pathog 2009; 5:e1000537; http://dx.doi.org/10.1371/journal.ppat.1000537; PMID: 19662165
  • Zhang JZ, Ng MH, Xia NS, Lau SH, Che XY, Chau TN, et al. Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J Med Virol 2001; 64:125 - 32; http://dx.doi.org/10.1002/jmv.1027; PMID: 11360244
  • Zhang J, Liu CB, Li RC, Li YM, Zheng YJ, Li YP, et al. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine 2009; 27:1869 - 74; http://dx.doi.org/10.1016/j.vaccine.2008.12.061; PMID: 19168109
  • Wu T, Zhu FC, Huang SJ, Zhang XF, Wang ZZ, Zhang J, et al. Safety of the hepatitis E vaccine for pregnant women: A preliminary analysis. Hepatology 2011; In press http://dx.doi.org/10.1002/hep.25522; PMID: 22161542
  • Sarin SK, Kumar M. A vaccine for hepatitis e: has it finally arrived?. Gastroenterology 2011; 140:1349 - 52, discussion 1352-3; http://dx.doi.org/10.1053/j.gastro.2011.02.040; PMID: 21354166
  • Shrestha MP, Scott RM, Joshi DM, Mammen MP Jr., Thapa GB, Thapa N, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356:895 - 903; http://dx.doi.org/10.1056/NEJMoa061847; PMID: 17329696

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.